Biocryst Pharmaceuticals (BCRX) Current Assets (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Current Assets of $484.68 million in Q2 2026, up 21.6% from $398.46 million a year earlier and up 29.7% from the prior quarter.
Biocryst Pharmaceuticals (BCRX) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals reported Current Assets of $404.35 million, down 4.2% from FY2024.
- Annual Current Assets has declined for four straight years, though with a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $421.97 million in FY2024 (-14.9%), $495.97 million in FY2023 (-4.0%), $516.5 million in FY2022 (-8.8%) and $566.14 million in FY2021 (+74.8%).
- The Q2 2026 figure is the highest quarterly Current Assets since Q4 2023.
- On a year-over-year basis, Current Assets rose in two of the last eight quarters, with an average decline of 4.6%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 101.4% in Q3 2022, against a decline of 28.9% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $373.63 million (Q1 2026), $404.35 million (Q4 2025) and $355.68 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 940.71 Mn | 214.41 Mn | 484.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 484.68 Mn |
| Mar 31, 2026 | 373.63 Mn |
| Dec 31, 2025 | 404.35 Mn |
| Sep 30, 2025 | 355.68 Mn |
| Jun 30, 2025 | 398.46 Mn |
| Mar 31, 2025 | 409.98 Mn |
| Dec 31, 2024 | 421.97 Mn |
| Sep 30, 2024 | 427.13 Mn |
| Jun 30, 2024 | 363.46 Mn |
| Mar 31, 2024 | 447.10 Mn |
| Dec 31, 2023 | 495.97 Mn |
| Sep 30, 2023 | 502.47 Mn |
| Jun 30, 2023 | 511.06 Mn |
| Mar 31, 2023 | 490.88 Mn |
| Dec 31, 2022 | 516.50 Mn |
| Sep 30, 2022 | 509.00 Mn |
| Jun 30, 2022 | 494.85 Mn |
| Mar 31, 2022 | 511.71 Mn |
| Dec 31, 2021 | 566.14 Mn |
| Sep 30, 2021 | 252.74 Mn |
Biocryst Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();